Murchinson Ltd. Has $10.17 Million Stake in Amedisys, Inc. (NASDAQ:AMED)

Murchinson Ltd. lessened its holdings in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 15.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 105,376 shares of the health services provider's stock after selling 18,603 shares during the quarter. Amedisys makes up approximately 2.8% of Murchinson Ltd.'s investment portfolio, making the stock its 8th largest position. Murchinson Ltd. owned approximately 0.32% of Amedisys worth $10,170,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of AMED. KBC Group NV acquired a new position in Amedisys during the third quarter worth approximately $63,000. Innealta Capital LLC acquired a new position in shares of Amedisys in the second quarter valued at approximately $64,000. Signaturefd LLC grew its position in shares of Amedisys by 88.2% in the second quarter. Signaturefd LLC now owns 1,131 shares of the health services provider's stock valued at $104,000 after purchasing an additional 530 shares during the last quarter. CWM LLC grew its position in shares of Amedisys by 14.5% in the third quarter. CWM LLC now owns 2,190 shares of the health services provider's stock valued at $211,000 after purchasing an additional 277 shares during the last quarter. Finally, Crossmark Global Holdings Inc. acquired a new position in shares of Amedisys in the third quarter valued at approximately $243,000. Institutional investors and hedge funds own 94.36% of the company's stock.

Amedisys Stock Performance

Shares of Amedisys stock traded down $0.65 on Wednesday, hitting $85.62. The stock had a trading volume of 721,319 shares, compared to its average volume of 366,253. Amedisys, Inc. has a twelve month low of $85.36 and a twelve month high of $98.95. The business's 50 day moving average is $94.41 and its two-hundred day moving average is $95.53. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05. The stock has a market cap of $2.80 billion, a price-to-earnings ratio of 34.23, a price-to-earnings-growth ratio of 1.92 and a beta of 0.73.

Amedisys (NASDAQ:AMED - Get Free Report) last posted its earnings results on Wednesday, November 6th. The health services provider reported $1.00 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.19). Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The firm had revenue of $587.67 million during the quarter, compared to analyst estimates of $586.75 million. During the same period in the previous year, the company posted $0.98 EPS. Amedisys's revenue for the quarter was up 5.7% compared to the same quarter last year. Analysts forecast that Amedisys, Inc. will post 4.53 EPS for the current year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.